KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance. [electronic resource]
Producer: 20160726Description: 796-802 p. digitalISSN:- 1436-3305
- Aged
- Antineoplastic Agents -- therapeutic use
- Blotting, Western
- Cell Transdifferentiation -- genetics
- Chromatography, High Pressure Liquid
- DNA Mutational Analysis
- Drug Resistance, Neoplasm -- genetics
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate -- therapeutic use
- Immunohistochemistry
- Male
- Mutation
- Neoplasm Recurrence, Local -- genetics
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins c-kit -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Stomach Neoplasms -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.